Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients; X-MEN

Press/Media: Expert Comment

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleStudy for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients; X-MEN
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date10/2/18
    PersonsJung-Eun Kim